化合物MK8722 T16099
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
1 mg | 1394371-71-1 | ¥336.00 | 询底价 |
2 mg | 1394371-71-1 | ¥478.00 | 询底价 |
100 mg | 1394371-71-1 | ¥4,530.00 | 询底价 |
5 mg | 1394371-71-1 | ¥727.00 | 询底价 |
25 mg | 1394371-71-1 | ¥1,980.00 | 询底价 |
10 mg | 1394371-71-1 | ¥1,230.00 | 询底价 |
50 mg | 1394371-71-1 | ¥2,970.00 | 询底价 |
1 mL | 1394371-71-1 | ¥821.00 | 询底价 |
Product Introduction
Bioactivity
英文名: MK8722
描述: MK8722 是一种全身性泛 AMPK 激活剂。
体外活性: MK8722 is an effective, direct, allosteric activator of all 12 mammalian AMPK complexes. pAMPK activation by maximal AMP plus MK8722 is synergistic, demonstrating that the agents act at distinct sites. MK8722 activates pAMPK complexes with increased potency and magnitude versus AMP (EC50: ~1 to 60 nM) and increased activation by factors of ~4 to 24. Although MK8722 exhibits a higher affinity for β1-containing (~1 to 6 nM) versus β2-containing (~15 to 63 nM) pAMPK complexes, it is the most potent activator of β2 complexes reported to date .
体内活性: MK8722(once-daily)administration, causes dose-dependent lowering of ambient blood glucose. Chronic MK8722 dosing in mice also increases muscle Glut4 protein levels, possibly contributing to efficacy. Chronic antihyperglycemic efficacy of MK8722 is evaluated in db/db mice (a leptin receptor-deficient T2DM model). Glucose reductions after MK8722 treatment (30 mpk/day) are comparable to those observed with the PPARγ agonist BRL49653 (3 mpk/day), on treatment day 12. Dose-dependent enhances in tissue pACC are maintained throughout the dosing period. Chronic efficacy, without tachyphylaxis, is also observed in additional dysmetabolic and diabetic rodent models. In all cases, efficacy is associated with trough MK8722 plasma levels comparable to the concentrations required to acutely stimulate skeletal muscle glucose uptake. The glucose-lowering action of MK8722 manifests without significant effects on body weight .
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 62.5 mg/mL (138.92 mM)
关键字: AMP-activated protein kinase | inhibit | Inhibitor | MK-8722 | AMPK | MK8722 | MK 8722
相关产品: Brazilin | HTH-01-015 | Mogrol | ML753286 | PF-249 | HL271 | Euphorbiasteroid | Britannin | N,N-Didesethyl Sunitinib Hydrochloride | Hernandezine
相关库: Anti-Aging Compound Library | Anti-Cancer Metabolism Compound Library | ReFRAME Related Library | Anti-Cancer Compound Library | Neuronal Differentiation Compound Library | Anti-Ovarian Cancer Compound Library | Antidepressant Compound Library | Kinase Inhibitor Library | Anti-Diabetic Compound Library | Epigenetics Compound Library
化合物MK8722 T16099信息由TargetMol中国为您提供,如您想了解更多关于化合物MK8722 T16099报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途